The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease [PDF]
, 2001 Alaa A. Kandil +2 more
openalex +1 more source
British Journal of Haematology, EarlyView.A visual overview of the key findings from the 35 papers included in this systematic review evaluating the use of PET volumetric parameters in children, adolescents and young adults with Hodgkin lymphoma. Summary In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification.
S. Claire Gowdy +22 more
wiley +1 more source
British Journal of Pharmacology, EarlyView.Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley +1 more source
Monocyte-mediated inhibition of lymphocyte blastogenesis in Hodgkin disease [PDF]
, 1978 GP Schechter, F Soehnlen
openalex +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
British Journal of Pharmacology, EarlyView.Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen +3 more
wiley +1 more source
Development of Hodgkin Lymphoma in a Patient with Common Variable Immunodeficiency
İstanbul Medical Journal, 2019 Öner Özdemir +3 more
doaj +1 more source
Cancer Science, EarlyView.J‐MIND evaluated the safety and tolerability of tafasitamab, a CD19‐targeting monoclonal antibody, alone or in combination with other therapies in Japanese patients with B‐cell non‐Hodgkin lymphoma (NHL). Most common treatment‐emergent adverse events across all groups were hematological, and no serious tafasitamab treatment‐related or fatal adverse ...
Koji Izutsu +7 more
wiley +1 more source
Semen Quality in Patients with Hematological Malignancies: A Retrospective Monocentric Study in the Perspective of Personalized Oncofertility Medicine. [PDF]
J Pers MedCariati F +11 more
europepmc +1 more source
Epidemiologic Associations Between Inflammatory Bowel Disease and Hodgkin Lymphoma or Multiple Sclerosis [PDF]
Amnon Sonnenberg, Ruth Kohen
openalex +1 more source
Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO‐P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non‐Hodgkin lymphoma [PDF]
, 2005 Antonino Musolino +9 more
openalex +1 more source